baclofen has been researched along with Prostatic Hyperplasia in 1 studies
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, H | 1 |
| Inamoto, T | 1 |
| Sakamoto, T | 1 |
| Kiyama, S | 1 |
| Ubai, T | 1 |
| Shinohara, Y | 1 |
| Maemura, K | 1 |
| Tsuji, M | 1 |
| Segawa, N | 1 |
| Masuda, H | 1 |
| Takahara, K | 1 |
| Katsuoka, Y | 1 |
| Watanabe, M | 1 |
1 other study available for baclofen and Prostatic Hyperplasia
| Article | Year |
|---|---|
Gamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism.
Topics: Aged; Aged, 80 and over; Baclofen; Dipeptides; Enzyme Induction; GABA Agonists; GABA-B Receptor Agon | 2003 |